News & Announcements

Filter by year:

GARDP and Bugworks to collaborate on a broad-spectrum antibiotic

June 12, 2024 Published in CIDRAP

Bengaluru company, global initiative to take new compound against superbugs to patients

June 11, 2024 Published in timesofindia.com

Global Antibiotic R&D Partnership (GARDP) and Bugworks Research Inc. are joining forces to co-develop an innovative compound (BWC0977) with broad-spectrum antibiotic activity against multidrug-resistant bacteria that cause life-threatening infections.

June 11, 2024 Published in bugworksresearch.com

Bugworks has recently been featured in the Times of India, highlighting the global impact of antimicrobial resistance (AMR) and the innovative research conducted in India to combat this global pandemic.

February 19, 2024 Published in timesofindia.com

Bugworks Research Inc. to Present Poster at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2023, in Geneva, Switzerland

December 7, 2023 Published in PR Newswire (CISION)

An article by Dr. Vasanthi Ramachandran, Vice President, highlights the pressing need for innovation in antibiotics research and development.

November 27, 2023 Published in downtoearth.org

Bugworks and GARDP join forces to accelerate development of a novel antibiotic to treat serious bacterial infections.

July 28, 2023 Published in GARDP

An engaging and informative podcast titled “What can we do to stop superbugs?” by Dr Anand Anandkumar, CEO with Alisha Wainwright onbehalf of Wellcome Trust.

June 28, 2023 Published in Wellcome Trust

Dr Santanu Datta and Vasan Sambandamurthy from Bugworks have contributed a chapter titled “Bugworks is a beacon of hope in the discovery of novel antibacterial agents” in the book “No Option: The Hidden Crisis and Hope for AMR“ presented by the AMR Declaration Trust.

June 22, 2023 Published in book by AMR DECLARATION TRUST

An article by Leela Maitreyi, Director, “Antimicrobial Resistance And Its Impact On Public Health”.

June 09, 2023 Published in Indiatimes

Dr Vasanthi Ramachandran, Vice President, interview with Neo Science Hub.

May 17, 2023 Published in neosciencehub.com

Dr. Vasan Sambandamurthy, Senior Vice President, interview with BioVoice News.

April 13, 2023 Published in biovoicenews.com

Bugworks featured in Fortune India article about Pharma’s R&D ambitions Going global!

April 05, 2023 Published in Fortune India

Insights into the advancement of immuno-oncology in India authored by Leela Maitreyi in Times of India.

March 02, 2023 Published in timesofindia.com

Former secretary of the Department of Biotechnology, Government of India and reputed Biotechnologist Dr Renu Swarup join the Global Advisory Board of Bugworks Research Inc. to provide strategic guidance to the project portfolio of Bugworks.

February 21, 2023 Published in Express Pharma

Dr Vasan Sambandamurthy, Senior Vice President shares details about the company’s key initiatives, including how its lead antibacterial asset is undergoing first-in-human phase-I clinical trials in an interview for BioVoice News magazine.

February 13, 2023 Published in biovoicenews.com

Podcast of Dr. Vasan Sambandamurthy (Senior Vice-President, Bugworks Research) in conversation with Dr. Chitra Pattabiraman from IDRF Speaks covering a range of topics – including opportunities and challenges in developing drugs and vaccines for tuberculosis, a career in industry vs academia, global burden of antimicrobialresistance (AMR), the current landscape of AMR research, how Bugworks Research Inc. is creating innovative solutions to tackle AMR, current research funding in India, the role of mentors and influencers in one’s career.

January 21. 2023 Published in IDRF Speaks

Bugworks Research Inc. is honoured to get a mention in the G20 press release from CARB-X with a particular reference to our CEO Dr Anand Anandkumar’s opinion on the AMR crisis.

December 21, 2022 Published in CARB-X

Dr. Anand Anandkumar CEO of Bugworks Research Inc., partakes in a webinar organised by the AMR Declaration Trust discussing on the role India can play in tackling the global challenge of Antimicrobial resistance.

November 19, 2022 Published in AMR Declaration Trust

Anand Anandkumar, co-founder and chief executive officer of Bugworks, explains what his company is doing to help discover and develop new antibiotics in an episode of One World, One Health with Maggie Fox.

October 07, 2022 Published in CDDEP.org

Bugworks Research Inc. as an exemplar of early success in the Indian biotech startup ecosystem.

September 19, 2022 Published in Forbes India

Bugworks Research Inc. and Cytecare announce collaboration to accelerate Immuno-oncology therapies.

September 19, 2022 Published in economictimes.com

Bugworks Research Inc. and Cytecare Cancer Hospitals announce collaboration to accelerate the development of cutting-edge Immuno-oncology therapies

September 18, 2022 Published in PR Newswire (CISION)

“Double whammy of antimicrobial resistance and sepsis: Need for innovative solutions” A short perspective in today’s Times of India by Vasan Sambandamurthy, Senior Vice President Bugworks Research Inc.

June 23, 2022 Published in The Times of India

GARDP supports Bugworks in assessing safety of new antibiotic compound

June 13, 2022 Published in Biovoiccenews.com

GARDP Supports Bugworks in Assessing Safety of New Antibiotic Compound

June 11, 2022 Published in Media Bulletins

GARDP Supports Bugworks in Assessing Safety of New Antibiotic Compound

June 11, 2022 Published in Business News

GARDP, Bugworks to collaborate on phase 1 trial for new antibiotic

June 10, 2022 Published in CIDRAP News

Please listen to Anand Anandkumar, CEO and MD of Bugworks Research Inc., in conversation with Harichandan Arakali for Forbes India, talking about the opportunity for India as a country to become a biotech powerhouse.

May 23, 2022 Published in Forbes India

Mention of Bugworks series B1 funding round – Inc42

May 21, 2022 Published in Forbes India

Looming threat of antimicrobial resistance” – how the Covid-19 pandemic has worsened the global AMR crisis on multiple fronts – a short perspective in today’s Deccan Herald written by Vasan Sambandamurthy.

May 17, 2022 Published in Deccan Herald

Listen to our CEO Dr Anand Anandkumar speak to BioSpectrum India on “#startupoftheday 143- Bugworks Research India Pvt Ltd” and a video message from our COO Dr Bala Subramanian on what we do each day to make a significant difference in the lives of needy patients with drug-resistant bacterial infections or hard-to-treat cancers.

April 01, 2022 Published in BioSpectrum

Vasan Sambandamurthy Senior Vice President of Global Operations at Bugworks Research Inc. perspective on banning the usage of Streptomycin and tetracycline in agriculture towards reduction of AMR burden.

March 22, 2022 Published in Healthworld.com

The third edition of Aspire’s Impact Future Project (IFP) on “Healthcare, Pharma & HealthTech” has recognised Bugworks Research Inc. as one of the top StartUps in the “Pharma, Drug & Vaccine Manufacturing” category.

March 5, 2022 Published in Impact Future Project

Bugworks was chosen as one of 20 biotech companies in the Indian subcontinent that are innovating the industry and making the world a better place

February 28, 2022 Published in Scispot.com

The Crisis of AMR in India – Deccan Herald News article on 17th February 2022 includes expert comments by Dr Santanu Datta, Co-Founder and CSO of Bugworks Research Inc.

February 17, 2022 Published in Deccan Herald

Bugworks Research Inc. secures US$18M series B1 funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa & India), led by Lightrock India. Syndicate includes – Lightrock, UTEC – The University of Tokyo Edge Capital Partners, Global Brain Corporation, 3one4 Capital, Acquipharma Holdings S.A, I.M Holdings B.V, Featherlite 

This round also saw the participation of two global iconic key opinion leaders – Dr. Kiran Mazumdar Shaw and Lord Jim O’Neill

February 9, 2022 Published in PR Newswire (CISION)

Bugworks Research Inc. raises $18M in series B1 round led by Lightrock India, others.

February 9, 2022 Published in Yourstory.com

Bugworks Research Inc. bags $18 million in a funding round led by Lightrock India, others.

February 8, 2022 Published in economictimes.com

Bugworks Research Inc. CSO Dr. Santanu Datta underscores need for a Bayh-Dole like Act to propel research commercialization

November 15, 2021 Published in Pharmabiz.com

Bugworks Research starts first human dose study to treat critical bacterial infections – ETHealthWorld

November 10, 2021 Published in ETHealthworld.com

Bugworks Research begins first in human phase 1 study of BWC0977 to treat critical bacterial infections

November 9, 2021 Published in Pharmabiz.com

Indian innovation at work: Bugworks embarks on phase I trials in its pursuit for a new antibiotic

November 9, 2021 Published in FEHealthcare.com

Bugworks is proud to announce First in Human phase 1 studies of BWC0977 for the treatment of critical bacterial infections – first novel broad spectrum in decades

November 8, 2021 Published in PR Newswire (CISION)

Dr. Santanu Datta explores the future of drug development and the tension between access and excess

September 21, 2021 Published in BSAC

Bugworks Co-Founder Bala Subramanian features in the FORBES India Marquee edition on ‘Leaders by Example”

July 15, 2021 Published in Forbes India

Bugworks one of four global companies exemplified in this latest AMR report from Access to Medicines Foundation

June 11, 2021 Published in Access to Medicine Foundation

G7 health ministers make AMR an important facet of pandemic preparedness and vow to incentivise this space

June 6, 2021 Published in G7 Health Ministers Communique

Bugworks featured amongst the top 5 innovative Biotech companies to look out for in India by Pharmareg News.

May 25, 2021 Published in pharmaregnews.com

Bugworks secures support from US Government’s Defense Threat Reduction Agency (DTRA) to validate its clinical asset against the toughest bacterial biothreats

April 27, 2021 Published in PR Newswire (CISION)

Dr. Oppel Greeff, Bugworks’ investor and member of SAB, wins the prestigious Havengaprize by the South Africa Academy of Art and Science

April 26, 2021 Published in MedPharm Publications

Bugworks’ CEO interviewed by the Financial Express as part of a story done on World innovation day!

April 22, 2021 Published in financialexpress.com

Anand Anandkumar, Bugworks’ CEO has been re-nominated into the Board of AMR Industry Alliance and will serve as key member of the Biotech Working Group within this global alliance.

April 15, 2021 Published in amrindustryalliance.org

Anand Anandkumar has been selected by CEO Insights Magazine for ‘Top 10 Best Leaders in Biotechnology in India 2021’

April 12, 2021 Published in ceoinsightsindia.com

Bugworks on BBC’s people fixing the world podcast.

March 15, 2021 Published in BBC News

Bugworks Research, one of the three companies to be showcased in GlobalBioIndia event 2021.

March 02, 2021 Published in globalbioindiavirtual.com

Japanese venture company UTEC – The University of Tokyo Edge Capital Partners is enabling world class innovation from India in lifesciences – Bugworks Research Inc. as an exemplar!

February 01, 2021 Published in Forbes Japan

ALCOR Fund has chosen Bugworks as one of top 10 most innovative biotech startups in India

January 25, 2021 Published in ALCOR News

Bugworks showcased as pioneering start-up in Indian biotech, attracting global funding.

January 18, 2021 Published in economictimes.com

Dr.Anand Anandkumar Co-Founder and CEO of Bugworks Research Inc. has been inducted into Basel area innovation India Board (BIIB).

January 11, 2021 Published in baselarea.swiss

Anand Anandkumar of Bugworks joins the AMR Insights Ambassador Network Amsterdam

December 22, 2020 Published in amr-insights.com

CARBX wins the coveted award for Global innovation from GHTC; awards video features Bugworks as one of the product developers within CARBX family!

December 22, 2020 Published in GHTC News

Article by Bugworks featured in Antimicrobial Resistance campaign by Mediaplanet, distributed with Guardian UK

November 27, 2020 Published in issuu.com

Bugworks chosen as number 5 within the top 10 innovative Biotech companies in India

November 27, 2020 Published in Backstage with Millionaires

Anand Anandkumar interviewed by Financial times for a special story on AMR

November 19, 2020 Published in Financial Times

‘Antibiotic Resistance – video piece in the FT’, Bugworks is happy to have contributed to the narrative.

November 18, 2020 Published in Financial Times

‘The world better be prepared for a silent pandemic” – article by Bugworks featured in the Guardian UK

November 18, 2020 Published in globalcause.co.uk

Bugworks featured in an AMR Communique by Financial Times – October 2020

October 27, 2020 Published in Financial Times

Dr. Anand is speaking at the ASPIRE Webinar series.

October 06, 2020 Published in ASPIRE News

The Global Antibiotic Research and Development Partnership (GARDP) and Bugworks sign a MOU to Explore Antibiotic Development to Tackle Serious Bacterial Infections in High-Burden Countries.

September 01, 2020 Published in GARDP News

Dr.Anand Anandkumar Co-Founder and CEO Bugworks Research Inc. addressing a panel on ‘Global markets | Why we need to think global to tackle AMR’ – at the BIOCOM AG AMR 2020 conference

August 26, 2020 Published in AMR Conference

Bugworks’ CEO Anand Anandkumar PhD, speaks at the pre-conference webinar “The AMR community and its current state of play – Insights into recent facts and figures”, organised by BIOCOM. Here you can access the recording and the presentations slides (password: 2020webinar)

August 07, 2020 Published in AMR Conference

A Plan to Avert a ‘Superbug’ Pandemic

July 13, 2020 Published in WSJ Opinion

New $1 billion fund aims to steer antibiotic companies in tough market

July 13, 2020 Published in Reuters

UPCOMING WEBINAR: 9th July – 9:00-10:30 am CEST – Anand Anandkumar from Bugworks and Kamini Walia of ICMR – to speak in a webinar organised by GARDp, on the topic “The challenges and opportunities for antimicrobial R&D in low- and middle-income countries – India case study”.

July 08, 2020 Published in GARDP News

Podcast – Leadership – From Now Into The Future – a dialog with Anand Anandkumar, Co-Founder and CEO, Bugworks

June 22, 2020 Published in buzzsprout.com

TERMSHEET Podcast: Swatting Superbugs with Anand Anandkumar of Bugworks

May 20, 2020 Published in Termsheet Podcast

Dr. Santanu Datta (co-founder CSO Bugworks) Finding Genius Podcast interview is now available.

May 14, 2020 Published in Finding Genius Podcast

Biopharma startup Bugworks raises $7.5 million in fresh financing round

May 06, 2020 Published in ET Rise

Biopharma startup Bugworks Research raises $7.5 mn in a fresh funding round. Megha Viswanath of CNBC-TV18 spoke with the CEO and Co-founder of Bugworks – Anand Anandkumar

May 01, 2020 Published in CNBC News18

Bugworks: breaking the U.S.-centric antimicrobial mold

April 29, 2020 Published in Biocentury.com

Biopharma Start-Up Bugworks Raises $7.5 Mln In Fresh Financing

April 28, 2020 Published in Entrepreneur.com

Bugworks raises $7.5M, will focus on pandemic preparedness

April 25, 2020 Published in Yourstory.com

Bugworks Raises US$7.5M From a Global Investment Syndicate to Combat the Global Challenge Posed by Deadly Bacterial Superbugs

April 23, 2020 Published in PRNewswire (CISION)

Bugworks invited as part of a global panel to present at – H20 Digital Dialogue Series with Dr Tedros Adhanom Ghebreyesus, World Health Organization

April 6, 2020 Published in H20 Digital Dialogue Series

Developing next-gen drugs to fight superbugs

February 4, 2020 Published in The Hindu

Bugworks CEO featured in this Times of India article – Retirement? These greypreneurs are just starting up

January 19, 2020 Published in TOI

Participating in INNOVATION INDIA 2020 at JP Morgan Conference, San Francisco, USA on January 14, 2020

January 14, 2020 Published in ABLE India

Mitsubishi UFJ Research and Consulting Company and Bugworks to collaborate in AMR

November 13, 2019 Published in MURC News

Bugworks’ CEO speaks at World AMR Congress 2019 in Washington DC

November 8, 2019 Published in World AMR Conference

Interview with Dr. Shahul Hameed VP, R&D, CNBC TV18 Startup Street

October 15, 2019 Published in CNBC News18

CARB X Annual Report – The Fight Against Superbugs

September, 2019 Published in CARB X Annual Report 2018-2019

Fears of infections pandemic grow after 19 new superbugs are discovered in the UK

September 11, 2019 Published in Dailymail.co.uk

Bugworks is an integral part of the CDC Global AMR Challenge

August 19, 2019 Published in CDC News

Bugworks pointed to as an example of the potential of drug discovery out of India

July 4, 2019 Published in Linkedin.com

Bugworks’s CEO represents the global AMR ecosystem at G20

June 29, 2019 Published in G20.org

News on Bugworks’s research featured in The Telegraph

April 30, 2019 Published in The Telegraph

How Bugworks is leading India’s AMR combat

April 26, 2019 Published in C-CAMP Innovation Insights

Bugworks’s CEO was one of the speakers at AMR global event

March 26, 2019 Published in Economist.com

Bugworks’s CEO was as a speaker at the 12th Berlin Conference of Life Sciences

March 15, 2019 Published in AMR Conference

Bugworks’s journey published in The Economic Times Prime

March 4, 2019 Published in ET Prime

Bugworks featured as one of the key science success stores from India

February 1, 2019 Published in Yourstory.com

Bugworks elected to the Board of AMR Industry Alliance

February 21, 2019 Published in Economist.com

Bugworks’s CEO interviewed on Yourstory

February 19, 2019 Published in Yourstory.com

Bugworks all set for pre-clinical drug trials

December 8, 2018 Published in Economic Times

Bugworks in The Economic Times on how Startup India is finding echoes across states

November 25, 2018 Published in Economic Times

Bugworks in the 2019 global list of 36 game-changing startups

November 25, 2018 Published in CBinsights.com

Bugworks chosen as a global story chronicled by the Wellcome Trust

November 12, 2018 Published in Wellcome.org

Bugworks highlighted as a success story of the fledgling Indo-Japanese ties

November 2, 2018 Published in Startupindia.gov.in

Investments in new antibiotic research discussed at World Investment Forum

October 25, 2018 Published in IPwatch.org

GYROX getting ready to kill antibiotic-resistant superbugs

October 13, 2018 Published in Nanalyze.com

Bugworks’s CEO at YourStory’s TechSparks event

October 9, 2018 Published in Yourstory.com

Bugworks featured in a global story on the CDC and dept of HHS

September 27, 2018 Published in Healio.com

Bugworks takes on global leadership for the ongoing CDC/UN AMR Challenge

September 25, 2018 Published in CDC News

Bugworks’s CEO presenting at the CDC/UN event in New York

September 25, 2018 Published in AMR News

How entrepreneurs aged over 50 are busting the young founder myth – Yourstory

September 21, 2018 Published in Yourstory.com

Bugworks raises $9M Series-A financing to develop novel antibiotics to fight superbugs

August 14, 2018 Published in PRnewswire.com

The University of Tokyo Edge Capital invests in Bugworks

August 13, 2018 Published in Theindianwire.com

Bugworks bags Rs. 62 crore in Series-A – The Economic Times

August 13, 2018 Published in Economic Times

Bugworks raises $9M Series-A funding – Yourstory

August 13, 2018 Published in Yourstory.com

Bugworks featured in NDTV as a startup waging a war against superbugs

June 30, 2018 Published in NDTV

Bugworks featured in Bloomberg on how startups are waging war against superbugs

June 25, 2018 Published in Bloomberg

Bugworks as an exemplar in a Chemistry World article by Dr. Clare Sansom

March 2, 2018 Published in Chemistryworld.com

The US Ambassador to India on Bugworks

February 23, 2018 Published in Twitter.com

Bugworks featured in a select list of promising Indian Innovator companies – PGP report

February 15, 2018 Published in PGPpartners.com

Bugworks featured on the cover of Forbes

February 2, 2018 Published in Forbes India

Bugworks featured on Live Mint

January 30, 2018 Published in Livemint.com

Bugworks chosen as one of the best impact investment for 2017 by TOI

December 24, 2017 Published in TOI

Bugworks presents at Carnegie India’s Global Tech Summit 2017

December 10, 2017 Published in Yourstory.com

Bugworks being endorsed by CARB-X

November 22, 2017 Published in Pharmaceutical-technology.com

Bugworks on BBC news

November 22, 2017 Published in BBC

Startup Karnataka: Second to Bay Area, but catching up fast

October 25, 2017 Published in Yourstory.com

Bugworks featured in Pranjal Sharma’s book “Kranti Nation: India and the Fourth Industrial Revolution”

October 10, 2017 Published in Pranjal Sharma's book

Young Turks – How BIRAC is Oiling the Biotech Innovation Ecosystem

October 1, 2017 Published in CNBC News18

Why infections picked up in hospitals are the big threat today, how world is trying to cope

September 11, 2017 Published in Indianexpress.com

‘Bugworks Research’ in the Mission

July 27, 2017 Published in Medgenera News

Bugworks wins global grant from CARB-X to fight superbugs

July 26, 2017 Published in Yourstory.com

Bugworks gets CARB-X funding

July 26, 2017 Published in ET Tech

Optibrium and Bugworks Sign Agreement for StarDrop License

July 26, 2017 Published in Businesswire.com

Working on innovative AMR products

June 15, 2017 Published in Terrapinn News

India’s battle against ‘superbugs’

May 19, 2017 Published in France24

Bugworks among the 30 best startups – Insights Success

April 1, 2017 Published in Insights Success

The Startup That Aims to Rid India of Deadly Superbug Infections and Antibiotic Resistance

March 16, 2017 Published in Betterindia.com

Here’s What Inspired Three Indian Veterans to Innovate in the Antibiotics Domain

March 9, 2017 Published in Entrepreneur.com

Bugworks to get into biz development mode

February 20, 2017 Published in Deccanherald.com

How India’s flagship Biotech Ignition grant has made an impact on biotechnology industry

February 17, 2017 Published in Economic Times

Bugworks working on drug to fight deadly infection-causing superbugs

February 14, 2017 Published in Yourstory.com

The story of Bugworks – YourStory

February 8, 2017 Published in Yourstory.com

Now smaller firms developing antibiotics but will society, politicians accept high prices?

January 22, 2017 Published in Economic Times

India’s biotech capital spreads its wings

December 22, 2016 Published in Economic Times

Meet the top tech 25 startups from Karnataka

December 2, 2016 Published in Yourstory.com

Are India’s life sciences startups turning a corner?

September 9, 2015 Published in Economic Times

Bugworks’s biologists looking for life-saving patterns – The Economic Times

February 14, 2015 Published in Economic Times

Why Indian startups like Bugworks have entered the field of drug discovery

January 18, 2015 Published in Economic Times


to top